Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetic Polymorphism Linked to Nicotine Addiction

By Biotechdaily staff writers
Posted on 14 Jul 2003
Researchers have identified a specific genetic polymorphism linked to the metabolism of nicotine that may act to inhibit smokers from quitting but paradoxically also protects against the development of pulmonary emphysema.

Investigators at Keio University (Tokyo, Japan) obtained DNA samples from a group of 203 current or ex-smokers with suspected chronic obstructive pulmonary disease (COPD) and from a control group of 123 healthy non-smokers. More...
Basic lifestyle information, including the number of cigarettes consumed per day, the duration of smoking, and the time elapsed since quitting was compiled. Then CYP2A6 genotypes were determined for all participants.

The results, published in the July 2003 issue of Thorax, revealed that those carrying the CYP2A6del allele seemed to be inhibited from breaking the smoking habit, but that the allele also seemed to protect them against the development of pulmonary emphysema. The percentage of subjects with a CYP2A6del allele was lower in heavy smokers than in light smokers or non-smokers. It was also lower in ex-smokers than in current smokers.

The authors conclude, "These findings suggest that determination of the genotype will be useful in efficiently withdrawing patients from nicotine dependence in smoking cessation protocols with nicotine containing materials, and will give a new insight into the pathogenesis of smoking induced pulmonary emphysema.”




Related Links:
Keio University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.